Mark Cuban Proposes Five-Step Plan to Reform Healthcare Pricing
Billionaire entrepreneur targets PBM transparency and contractual reform to lower American drug costs.
1The Insurance Paradox
Mark Cuban highlights a systemic failure where insured patients often pay more for medications than cash prices at his pharmacy. During a September 1 Texas House hearing, he noted that 51% of U.S. adults struggle to afford care. This discrepancy signals that current insurance structures fail to provide genuine price competition.
2Incentivizing Cost Savings
Cuban proposes allowing patients to choose cheaper drug options without facing financial penalties. If a patient selects a lower-cost medication, that spending should count toward their deductibles and out-of-pocket maximums. This mechanism aims to reward consumers for saving their health plans money, effectively fostering a more competitive and transparent healthcare marketplace.
3Standardizing Middleman Contracts
Three major pharmacy benefit managers, including CVS Caremark and OptumRx, control roughly 80% of U.S. drug claims. Cuban labels their complex, lengthy contracts as contractual terrorism. He advocates for standardized templates to prevent government entities from negotiating from scratch, which currently results in a losing game for taxpayers and local public institutions.
4Mandating Public Pricing Data
Cuban argues that taxpayer-funded programs like Medicare and Medicaid must disclose pricing data, including rebates, fees, and affiliate compensation. Without this essential price discovery, markets cannot function efficiently because one party holds all the information. Transparency is the core ingredient required to fix the persistent affordability crisis in American healthcare.
5Eliminating Restrictive Gag Clauses
Gag clauses currently prevent employers and plan sponsors from openly discussing their contract terms. Cuban contends that these provisions block organizations from comparing fees and negotiating better deals for their employees. Removing these barriers is a critical step toward enabling informed decision-making and fostering a more open, competitive environment for drug procurement.
6Strengthening Regulatory Enforcement
Current penalties for healthcare companies are often viewed as mere costs of doing business rather than effective deterrents. Cuban suggests that regulators should impose significantly steeper fines on repeat offenders. He argues that companies currently write off fines more easily than personal penalties, necessitating a shift toward more meaningful, punitive regulatory consequences.
7Unlikely Political Alliances
Cuban’s crusade has created strange bedfellows, including a partnership with the White House-backed TrumpRx program. He also supports the Break Up Big Medicine Act, introduced by Senators Josh Hawley and Elizabeth Warren. This bipartisan interest reflects the growing urgency to address healthcare costs, which Cuban identifies as a primary threat to jobs.
8Structural Industry Implications
The proposed legislation aims to bar companies from simultaneously owning insurers, PBMs, and medical providers. While the Break Up Big Medicine Act remains in the Senate Judiciary Committee, Cuban continues to press for these structural changes. His focus remains on systemic reform rather than technological solutions like AI to stabilize American healthcare.
Original article: Fortune — Mark Cuban Proposes Five-Step Plan to Reform Healthcare Pricing